Quantum Biopharma Ltd. has become the subject of a class action lawsuit filed against Canadian banks CIBC and RBC, alleging illegal stock market manipulation of Quantum BioPharma shares. The lawsuit claims that between January 6, 2021, and October 15, 2025, shareholders who sold securities of Quantum Biopharma, formerly known as FSD Pharma Inc., suffered significant harm due to the alleged actions. Quantum Biopharma has announced its intention to seek appointment as a lead plaintiff in the case to help protect its shareholders' interests.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quantum Biopharma Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9605409-en) on December 19, 2025, and is solely responsible for the information contained therein.
Comments